ℹ️
🇬🇧
Search
Search for people relevant for "correction"
correction
Person
Class
Person
Publication
Programmes
Export current view
MUDr. Miroslav Veith Ph.D.
Academic staff at Third Faculty of Medicine
1 class
41 publications
Class
class
Student Research Activity
C3SVA0005 |
Third Faculty of Medicine
Publications
publication
Incidence of adverse events after loading phase of the brolucizumab therapy of neovascular AMD: Real-life evidence in the Czech Republic
2023 |
Third Faculty of Medicine, Faculty of Medicine in Hradec Králové, Central Library of Charles University, First Faculty of Medicine
publication
Biosimilar SB11 versus reference ranibizumab in neovascular age-related macular degeneration: 1-year phase III randomised clinical trial outcomes
2023 |
Third Faculty of Medicine, Faculty of Medicine in Hradec Králové, Central Library of Charles University
publication
Efficacy and Safety of the Aflibercept Biosimilar SB15 in Neovascular Age-Related Macular Degeneration: A Phase 3 Randomized Clinical Trial
2023 |
Third Faculty of Medicine, Central Library of Charles University
publication
Biosimilar SB15 versus reference aflibercept in neovascular age-related macular degeneration: 1-year and switching results of a phase 3 clinical trial
2023 |
Third Faculty of Medicine, Central Library of Charles University
publication
Laser Vitreolysis for Vitreous Opacities: A Prospective Study
2023 |
Third Faculty of Medicine
publication
Effect of baseline central retinal thickness on the results of treatment of diabetic macular edema with aflibercept: real-life evidence in the Czech republic
2022 |
Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
publication
Laser Vitreolysis in Patients with Symptomatic Vitreous Floaters
2022 |
Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
publication
Intravitreal ranibizumab in pregnant patient with myopic choroidal neovascular membrane. A case report
2022 |
Third Faculty of Medicine
publication
Efficacy and Safety of a Proposed Ranibizumab Biosimilar Product vs a Reference Ranibizumab Product for Patients With Neovascular Age-Related Macular Degeneration A Randomized Clinical Trial
2021 |
Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
publication
Two-year results of a combined regimen of aflibercept treatment in three types of choroidal neovascular membrane in the wet form of age-related macular degeneration: Real-life evidence in the Czech Republic
2021 |
Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
Load more publications (31)
Loading network view...